• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    11/7/23 1:10:11 PM ET
    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Telecommunications Equipment
    Utilities
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADTN alert in real time by email

    Gainers

    • PaxMedica, Inc. (NASDAQ:PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) gained 83% to $0.5298 after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Senti is eligible to receive up to $156 million in milestones and royalties.
    • Tharimmune, Inc. (NASDAQ:THAR) shares climbed 57.8% to $0.2488 as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.
    • TransMedics Group, Inc. (NASDAQ:TMDX) shares gained 56.7% to $63.03 after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance.
    • Singular Genomics Systems, Inc. (NASDAQ:OMIC) rose 39.1% to $0.5350.
    • Olaplex Holdings, Inc. (NASDAQ:OLPX) gained 39% to $1.92 following strong quarterly results.
    • Datadog, Inc. (NASDAQ:DDOG) climbed 28.6% to $102.28 after the company reported better-than-expected third-quarter results and issued strong guidance.
    • Augmedix, Inc. (NASDAQ:AUGX) shares rose 24% to $5.64 following strong third-quarter results.
    • Rover Group, Inc. (NASDAQ:ROVR) gained 23.7% to $7.99 following upbeat results. The company’s board also approved extension of share repurchase program with additional $100 million.
    • MacroGenics, Inc. (NASDAQ:MGNX) rose 20.6% to $6.57 after posting a profit for the third quarter.
    • Jowell Global Ltd. (NASDAQ:JWEL) climbed 18% to $1.96.
    • Triumph Group, Inc. (NYSE:TGI) rose 17.6% to $9.30 following strong quarterly results.
    • Alteryx, Inc. (NYSE:AYX) shares jumped 17.3% to $35.74 after the company reported better-than-expected third-quarter financial results.
    • Unisys Corporation (NYSE:UIS) shares jumped 16.7% to $3.3780 after the company posted upbeat third-quarter results and raised FY23 revenue growth forecast.
    • Thoughtworks Holding, Inc. (NASDAQ:TWKS) rose 16.2% to $4.2050 after the company posted upbeat third-quarter results.
    • TaskUs, Inc. (NASDAQ:TASK) gained 16% to $11.90 after the company reported better-than-expected third-quarter financial results and issued FY23 revenue guidance above estimates.
    • Myriad Genetics, Inc. (NASDAQ:MYGN) rose 15.8% to $18.92 after the company posted upbeat third-quarter results.
    • Planet Fitness, Inc. (NYSE:PLNT) climbed 15.8% to $63.92 after the company reported better-than-expected third-quarter financial results and raised FY23 revenue growth guidance.
    • EverQuote, Inc. (NASDAQ:EVER) gained 15.8% to $8.62 following strong sales.
    • Oscar Health, Inc. (NYSE:OSCR) climbed 14.3% to $6.53 following strong results.
    • Hims & Hers Health, Inc. (NYSE:HIMS) rose 13.9% to $7.16 after the company reported better-than-expected third-quarter sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
    • Surgery Partners, Inc. (NASDAQ:SGRY) rose 13.2% to $28.08 following upbeat results.
    • Vimeo, Inc. (NASDAQ:VMEO) gained 13.2% to $3.7950 following upbeat results.
    • MongoDB, Inc. (NASDAQ:MDB) climbed 12.7% to $374.62.
    • PRA Group, Inc. (NASDAQ:PRAA) climbed 11.3% to $16.12 following better-than-expected results.
    • Snowflake Inc. (NYSE:SNOW) rose 10.9% to $159.93 in sympathy with Datadog, which reported better-than-expected Q3 results and issued strong guidance.
    • DocGo Inc. (NASDAQ:DCGO) gained 10.2% to $6.39 following strong sales.
    • Wearable Devices Ltd. (NASDAQ:WLDS) surged 9.7% to $0.8006.
    • GSE Systems, Inc. (NASDAQ:GVP) rose 9.6% to $3.5961. GSE Solutions was recently awarded a $4.2 million contract from a large utility for nuclear power plant engineering work.
    • FibroGen, Inc. (NASDAQ:FGEN) gained 8.4% to $0.6062 following upbeat results.
    • Tripadvisor, Inc. (NASDAQ:TRIP) shares rose 4.8% to $16.89 after the company reported better-than-expected third-quarter financial results.

    Losers

    • Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares fell 80.8% to $2.71 after the company announced efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target to support further development of VTX958 in psoriasis.
    • Alto Ingredients, Inc. (NASDAQ:ALTO) fell 58.1% to $2.0594 after the company reported mixed third-quarter financial results.
    • Worldwide Webb Acquisition Corp. (NASDAQ:WWAC) fell 51% to $3.56.
    • Oportun Financial Corporation (NASDAQ:OPRT) fell 47% to $3.08 after reporting a loss for the third quarter.
    • Royalty Management Holding Corporation (NASDAQ:RMCO) dipped 41.6% to $5.80.
    • Aura Biosciences, Inc. (NASDAQ:AURA) fell 33% to $7.37. Aura Biosciences priced its public offering of 11 million common shares at $9 per share.
    • ThredUp Inc. (NASDAQ:TDUP) fell 30.5% to $2.3901 following weak results.
    • ADTRAN Holdings, Inc. (NASDAQ:ADTN) shares fell 28% to $5.28 following a wider-than-expected quarterly loss.
    • Olo Inc. (NYSE:OLO) fell 27% to $4.2650 following third-quarter results.
    • Ameresco, Inc. (NASDAQ:AMRC) shares declined 27% to $19.42 following downbeat third-quarter results.
    • Air Transport Services Group, Inc. (NASDAQ:ATSG) dropped 24.4% to $15.29. Air Transport Services reported weaker-than-expected results for its third quarter. The company also named Joe Hete, current Chairman of the Board and its former longtime CEO, as its CEO, effective immediately.
    • MSP Recovery, Inc. (NASDAQ:LIFW) shares fell 24.2% to $7.32 after jumping 252% on Monday.
    • Coherus BioSciences, Inc. (NASDAQ:CHRS) shares fell 23.2% to $2.72 after the company reported mixed third-quarter financial results.
    • Clover Health Investments, Corp. (NASDAQ:CLOV) shares fell 20.1% to $0.8966 following weak quarterly sales.
    • Nine Energy Service, Inc. (NYSE:NINE) fell 19.4% to $2.7631 following downbeat sales.
    • Tactile Systems Technology, Inc. (NASDAQ:TCMD) fell 17.2% to $10.46 following quarterly results.
    • Sterling Infrastructure, Inc. (NASDAQ:STRL) declined 16.3% to $62.42 following weak sales.
    • ICU Medical, Inc. (NASDAQ:ICUI) fell 16.3% to $85.34 following downbeat sales.
    • EverCommerce Inc. (NASDAQ:EVCM) dipped 15% to $8.16 following weak sales.
    • Sanmina Corporation (NASDAQ:SANM) shares fell 14.5% to $45.15 after the company reported worse-than-expected fourth-quarter financial results.
    • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) fell 11.4% to $12.49. Alpine Immune Sciences priced its $150 million public offering of 8.8 million common shares at $12.50 per share.
    • CNH Industrial N.V. (NYSE:CNHI) fell 8.6% to $10.36 after the company reported mixed third-quarter financial results and issued guidance.
    • Sage Therapeutics, Inc. (NASDAQ:SAGE) declined 7.4% to $19.09 following third-quarter results.

    Now Read This: Ethereum Falls Below This Key Level; Neo Becomes Top Loser

    Get the next $ADTN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTN
    $ALPN
    $ALTO
    $AMRC

    CompanyDatePrice TargetRatingAnalyst
    EverCommerce Inc.
    $EVCM
    3/13/2026Mkt Outperform → Mkt Perform
    Citizens
    Planet Fitness Inc.
    $PLNT
    3/12/2026$100.00Overweight
    KeyBanc Capital Markets
    Planet Fitness Inc.
    $PLNT
    3/11/2026$90.00Overweight
    Wells Fargo
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$24.00Sell → Neutral
    Citigroup
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$23.00Underperform → Neutral
    BofA Securities
    Hims & Hers Health Inc.
    $HIMS
    3/9/2026$30.00Hold → Buy
    Needham
    MongoDB Inc.
    $MDB
    3/5/2026$310.00Sector Perform → Sector Outperform
    Scotiabank
    MongoDB Inc.
    $MDB
    3/3/2026$260.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Desai Chirantan Jitendra

    4 - MongoDB, Inc. (0001441816) (Issuer)

    3/19/26 5:45:51 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Berry Michael J

    4 - MongoDB, Inc. (0001441816) (Issuer)

    3/19/26 5:45:16 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form 3 filed by new insider Berry Michael J

    3/A - MongoDB, Inc. (0001441816) (Issuer)

    3/19/26 5:44:39 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients

    SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), and a leading AI-powered physician-enablement platform today released a whitepaper titled "Driving Clinical Excellence in Chronic Disease: Counterpart Assistant's Role in Flu Preventative Care." The analysis examines the role of CA's real-time clinical insights on immunization rates and flu-related acute care utilization within Clover Health's Medicare Advantage (MA) population. Influenza remains a major cause of morbidity among Medicare beneficiaries, with 90% to 95% of flu-re

    3/19/26 8:30:00 AM ET
    $CLOV
    Medical Specialities
    Health Care

    Snowflake Launches Project SnowWork, Bringing Outcome-Driven AI to Every Business User

    Project SnowWork brings agentic intelligence directly to business users' desktops to accelerate productivity and get work done faster Designed to orchestrate planning, analysis, and execution, Project SnowWork is an autonomous enterprise AI platform that helps business users accelerate everyday work Launching in research preview to a limited set of customers, Project SnowWork handles complex, multi-step tasks and delivers real, data-driven outcomes to business users Project SnowWork brings Snowflake's vision for the agentic enterprise to life, where enterprise data, intelligence, and action are connected in a governed way Snowflake (NYSE:SNOW), the AI Data Cloud company, today a

    3/18/26 9:00:00 AM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®

    20th annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor, and the Company is one of only four honorees in the healthcare providers and services category. In 2026, 138 honorees were recognized, spanning 17 countries and 40 indu

    3/18/26 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Nakache Patricia bought $49,076 worth of shares (13,157 units at $3.73) (SEC Form 4)

    4 - ThredUp Inc. (0001484778) (Issuer)

    3/10/26 6:24:14 PM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    President and CEO Raha Samraat S. bought $199,844 worth of shares (40,000 units at $5.00), increasing direct ownership by 9% to 493,104 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    3/9/26 7:03:13 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Phanstiel S. Louise bought $494,722 worth of shares (104,507 units at $4.73), increasing direct ownership by 59% to 281,951 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    2/27/26 4:46:18 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    SEC Filings

    View All

    SEC Form 8-K filed by TripAdvisor Inc.

    8-K - TripAdvisor, Inc. (0001526520) (Filer)

    3/19/26 4:05:26 PM ET
    $TRIP
    Computer Software: Programming Data Processing
    Technology

    Senti Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Senti Biosciences, Inc. (0001854270) (Filer)

    3/19/26 4:02:14 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form POS AM filed by Wearable Devices Ltd.

    POS AM - Wearable Devices Ltd. (0001887673) (Filer)

    3/19/26 4:01:50 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    EverCommerce downgraded by Citizens

    Citizens downgraded EverCommerce from Mkt Outperform to Mkt Perform

    3/13/26 8:45:11 AM ET
    $EVCM
    Computer Software: Prepackaged Software
    Technology

    KeyBanc Capital Markets initiated coverage on Planet Fitness with a new price target

    KeyBanc Capital Markets initiated coverage of Planet Fitness with a rating of Overweight and set a new price target of $100.00

    3/12/26 8:54:26 AM ET
    $PLNT
    Hotels/Resorts
    Consumer Discretionary

    Wells Fargo initiated coverage on Planet Fitness with a new price target

    Wells Fargo initiated coverage of Planet Fitness with a rating of Overweight and set a new price target of $90.00

    3/11/26 8:39:34 AM ET
    $PLNT
    Hotels/Resorts
    Consumer Discretionary

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care

    Investment Alert: Stock Acquired at Air Transport Services Group Inc on Jun 7

    ```html Recently, on June 7, 2024, insider Berger Michael L made a significant purchase of Air Transport Services Group Inc shares, acquiring $49,830 worth of stock, which amounted to 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units and was disclosed in the SEC Form 4 filing "Berger Michael L bought $49,830 worth of shares (3,996 units at $12.47), increasing direct ownership by 4% to 103,705 units (SEC Form 4)". When analyzing this insider purchase in conjunction with other recent transactions within Air Transport Services Group Inc, several patterns emerge that could provide insights into the company's prospects and the conf

    6/10/24 12:24:42 AM ET
    $ATSG
    Air Freight/Delivery Services
    Consumer Discretionary

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Leadership Updates

    Live Leadership Updates

    View All

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs' Vision

    Yokneam Illit, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced a significant expansion of its AI expert advisory board. This strategic enhancement strengthens the Company's commitment to advancing neural AI innovation through ai6 Labs. The recently launched ai6 Labs is focused on advancing the Company's revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a closed-loop ecosystem designed to seamlessly connect hu

    3/16/26 8:45:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

    BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser

    3/12/26 6:12:07 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results

    DENVER, March 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ:EVCM), a leading AI-powered platform helping service SMBs run smarter and grow faster, announced today financial results for the quarter and year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue from continuing operations of $151.2 million, an increase of 5.2% compared to $143.7 million for the quarter ended December 31, 2024. Pro forma revenue increased approximately 4.6% compared to $144.5 million for the quarter ended December 31, 2024.Subscription and transaction fee revenue from continuing operations of $144.1 million, an increase of 4.7% compared to $137.6

    3/12/26 4:05:00 PM ET
    $EVCM
    Computer Software: Prepackaged Software
    Technology

    Wearable Devices Reports Full Year 2025 Financial Results, Highlights Revenue Growth, $24.4 Million Raised in 2025 and $18.4 Million Cash Position

    YOKNE'AM ILLIT, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced its financial results for the year ended December 31, 2025. The Company reported revenue growth for the year, driven in part by a 28.5% increase in sales of its Mudra Link and Mudra Band products, reflecting growing adoption of its gesture-control technology and continued expansion of its business-to-client ("B2C") segment. Management Commentary "We are pleased to conclude 2025 with steady momentum in our B2C sector, drive

    3/12/26 9:00:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $ADTN
    $ALPN
    $ALTO
    $AMRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care